01Dec
Americas Antitrust Review 2021
Covid-19 has made 2020 into a year like no other with ‘stay at home’ orders and working from home the new normal. Nonetheless, the tech and pharma industries continued to attract immense antitrust scrutiny, with daily reports in the media and pressure from politicians to address what some perceive to be anticompetitive mergers by digital platforms and pharmaceutical companies, even while innovation in both sectors continues at breakneck speed. In this article, we discuss some of the most...
By:
Cooley LLP
Related
With the March 31 deadline to correct form defects in plan documents under the Initial Remedial Amen...
Read More >
This Is The 2nd Of A Trilogy Of Blogs Addressing The E-2 Visa Option Post The November 21 Change In ...
Read More >
The EEOC has rescinded its 1997 Policy Statement on Mandatory Binding Arbitration of Employment Disc...
Read More >
On January 13, 2020, in an opinion authored by Chief Justice Collins J. Seitz, Jr., the Supreme Cour...
Read More >
In 2020, the COVID-19 pandemic wreaked havoc on global public health systems, the financial markets,...
Read More >
To ensure the protection of the safety and health of employees, the French Supreme Court reiterated ...
Read More >